Invention Grant
- Patent Title: Enhancer of zeste homolog 2 inhibitors
- Patent Title (中): 味精同系物2抑制剂的增强剂
-
Application No.: US14400896Application Date: 2013-05-15
-
Publication No.: US09562041B2Publication Date: 2017-02-07
- Inventor: Joelle Lorraine Burgess , Steven David Knight
- Applicant: GlaxoSmithKline LLC
- Applicant Address: US DE Wilmington, New Castle
- Assignee: GlaxoSmithKline LLC
- Current Assignee: GlaxoSmithKline LLC
- Current Assignee Address: US DE Wilmington, New Castle
- Agent Duke M. Fitch; Kathryn A. Lutomski; Edward R. Gimmi
- International Application: PCT/US2013/041115 WO 20130515
- International Announcement: WO2013/173441 WO 20131121
- Main IPC: C07D211/86
- IPC: C07D211/86 ; C07D417/12 ; C07D213/64 ; C07D401/12
Abstract:
This invention relates to novel substituted benzamides according to Formula (I) which are inhibitors of Enhancer of Zeste Homolog 2 (EZH2), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of cancers.
Public/Granted literature
- US20150126522A1 ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS Public/Granted day:2015-05-07
Information query
